Novel Depression Tx Win; 96-Year-Old Psychiatrist Still At It; Teen Suicide Patterns

(MedPage Today) -- The novel once-daily kappa opioid receptor antagonist navacaprant significantly reduced symptoms of depression and anhedonia in participants with moderate-to-severe major depressive disorder in a phase II study, developer Neumora...
Source: MedPage Today Psychiatry - Category: Psychiatry Source Type: news